Detalhe da pesquisa
1.
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
J Pediatr
; 143(4): 532-40, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14571236